Literature DB >> 7541285

Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats.

T Hérembert1, D L Zhu, P Marche.   

Abstract

1. To gain insight into the parameters which control vascular structure, we investigated the mechanisms whereby nifedipine, and other dihydropyridines, inhibit the growth of cultured fibroblasts isolated from the adventitia of the aorta of spontaneously hypertensive (SHR) and normotensive Wistar Kyoto (WKY) rats. 2. The effects of nifedipine on cell proliferation and on serum-induced DNA synthesis were determined by measuring the cell number and the incorporation of [3H]-thymidine, respectively. The mechanism of action of nifedipine was studied by adding the drug either to randomly growing cells or to quiescent, G0/G1 arrested and synchronized cells. The effects of varying the duration of drug treatment were also examined. 3. In randomly growing cultures nifedipine, like other dihydropyridines concentration-dependently inhibited cell proliferation; the rank order of effect (measured at a concentration of 10 microM) was nifedipine > nisoldipine > nitrendipine approximately nimodipine. 4. In G0/G1 arrested cell cultures, nifedipine concentration-dependently inhibited serum-induced [3H]-thymidine incorporation. In this respect it had similar effects in cell cultures from WKY and SHR. In both SHR and WKY cultures, nifedipine delayed the transition from G0/G1 to S phase, and inhibited serum-induced DNA synthesis possibly by acting on the early G1 phase. 5. In cell cultures from both SHR and WKY, serum-induced DNA synthesis was similarly (approximately 40%) inhibited after a 1 day treatment with 10 microM nifedipine. In contrast, after 5 days treatment with the drug, the inhibition of DNA synthesis was approximately 65% and approximately 10% in SHR and WKY cultures, respectively. The inhibitory effects of nifedipine against proliferation of fibroblasts were 25% and 60%, respectively,after 1 and 5 days of treatment, and were similar in cells derived from SHR and WKY. This indicates that 5 days treatment with nifedipine inhibited the proliferation of SHR and WKY fibro blasts by acting mostly on the early G1 phase and the M phase, respectively.6. Irrespective of the duration of treatment (1 or 5 days) with 10 microM nifedipine, the inhibition of DNA synthesis could be abolished and partially reduced by Bay K 8644 (1 microM) in WKY and SHR fibroblasts,respectively. In cell cultures from both SHR and WKY the inhibitory effects of a short term and of along term treatment with nifedipine against cell proliferation were reduced and unaffected, respectively by Bay K 8644.7. These results indicate that nifedipine inhibited cell proliferation and serum-induced DNA synthesis by altering the cell cycle through different mechanisms in SHR and WKY fibroblasts. They also suggest the existence in aortic fibroblasts of interactions between calcium channel blockers of the dihydropyridine series and the mitogenic signalling pathways of growth factors contained in serum.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541285      PMCID: PMC1510376          DOI: 10.1111/j.1476-5381.1995.tb14960.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Voltage-sensitive calcium channels in normal and transformed 3T3 fibroblasts.

Authors:  C F Chen; M J Corbley; T M Roberts; P Hess
Journal:  Science       Date:  1988-02-26       Impact factor: 47.728

2.  Control of expression of the 1,4-dihydropyridine receptor in BC3H1 cells.

Authors:  D Rampe; J M Caffrey; M D Schneider; A M Brown
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

Review 3.  Physiological aspects of primary hypertension.

Authors:  B Folkow
Journal:  Physiol Rev       Date:  1982-04       Impact factor: 37.312

4.  The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation.

Authors:  J Nilsson; M Sjölund; L Palmberg; A M Von Euler; B Jonzon; J Thyberg
Journal:  Atherosclerosis       Date:  1985-12       Impact factor: 5.162

5.  Collagen and elastin synthesis in the aorta of spontaneously hypertensive rats.

Authors:  Z Deyl; J Jelínek; K Macek; G Chaldakov; V N Vankov
Journal:  Blood Vessels       Date:  1987

6.  Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia.

Authors:  G K Owens; S M Schwartz
Journal:  Circ Res       Date:  1982-09       Impact factor: 17.367

7.  Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents.

Authors:  A Ooshima; G C Fuller; G J Cardinale; S Spector; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

8.  1,4-Dihydropyridine receptor associated with Ca2+ channels in human embryonic fibroblasts.

Authors:  S M Dudkin; S N Gnedoj; N N Chernyuk; N M Soldatov
Journal:  FEBS Lett       Date:  1988-06-20       Impact factor: 4.124

9.  Involvement of calcium channels in fibroblast growth factor-induced activation of arterial cells in spontaneously hypertensive rats.

Authors:  D L Zhu; T Hérembert; D Caruelle; J P Caruelle; P Marche
Journal:  J Cardiovasc Pharmacol       Date:  1994-03       Impact factor: 3.105

10.  Binding of [3H]nitrendipine to cardiac and cerebral membranes from normotensive and renal, deoxycorticosterone/NaCl and spontaneously hypertensive rats.

Authors:  K Ishii; T Kano; J Ando; H Yoshida
Journal:  Eur J Pharmacol       Date:  1986-04-16       Impact factor: 4.432

View more
  1 in total

1.  The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Ilona Uzieliene; Eiva Bernotiene; Greta Rakauskiene; Jaroslav Denkovskij; Edvardas Bagdonas; Zygmunt Mackiewicz; Narunas Porvaneckas; Giedrius Kvederas; Ali Mobasheri
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.